Lee Schulman’s term “pedagogical solitude” captures a pervasive problem in academic teaching: many of us teach in isolation, with few opportunities for intellectual or creative exchange with fellow ...

The talks aim to lower costs for some of the most expensive treatments used by seniors; results of the first round of negotiations with drug makers went into effect this year. HealthDay News — Fifteen ...

The medications chosen for this negotiation cycle represent roughly $27 billion in total prescription drug spending under Medicare Part B and Part D. HealthDay News — Fifteen prescription medications, ...

The popular type 2 diabetes drug dulaglutide (Trulicity), botulinum toxin (Botox), and drugs to treat psoriatic arthritis, prostate cancer, and breast cancer are among the 15 drugs that the Centers ...

Ozempic has become so embedded in global culture that “Ozempic face” was shortlisted for a prominent dictionary’s word of the year in 2025. Ozempic isn’t the only drug that mimics the natural GLP-1 ...

Add Yahoo as a preferred source to see more of our stories on Google. President Donald Trump and the Centers for Medicare & Medicaid Services (CMS) recently announced the 15 drugs whose prices they ...

The list includes Botox and the GLP-1 drug Trulicity. The negotiations stem from President Joe Biden’s Inflation Reduction Act of 2022, which gave the Centers for Medicare and Medicaid Services the ...

Since 2023, roughly 4,400 patients have filed lawsuits against weight loss drugmakers — including Novo Nordisk, which makes Ozempic and Wegovy, and Eli Lilly, which produces Mounjaro, Zepbound and ...

Fifteen prescription medications, including Botox and the diabetes drug Trulicity, will be the focus of federal price negotiations that could lower prices for Medicare patients. An outgrowth of the ...